Brief: TELA Bio, Inc. Sees FY revenue USD 60-65 million
09/08/2023 22:07
Aug 9 (Reuters) - TELA Bio, Inc. Outlook FY revenue USD 60-65 million. * Q2 net income USD -10.79 million * Q2 basic EPS USD -0.46 * Q2 income from operations USD -10.362 million * Q2 operating expenses USD 20.563 million * Q2 revenue USD 14.494 million vs. IBES estimate USD 14.4 million * Q2 gross profit USD 10.201 million
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview